Press "Enter" to skip to content

Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer’s | Neurology Advisor

Image from the www.neurologyadvisor.com article
“Investigators analyzed data from 10 clinical trials of patients with Alzheimer disease who received cholinesterase inhibitors or memantine. Patients with Alzheimer disease (AD) who receive cholinesterase inhibitors (ChEIs) or memantine in clinical trials experience greater cognitive decline than patients who receive neither medication, according to study results published in JAMA Network Open.”
Read the full story at neurologyadvisor.com